Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region.
about
Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Two-Year Safety and Efficacy E ...... in the Latin American Region.
@ast
Two-Year Safety and Efficacy E ...... in the Latin American Region.
@en
type
label
Two-Year Safety and Efficacy E ...... in the Latin American Region.
@ast
Two-Year Safety and Efficacy E ...... in the Latin American Region.
@en
prefLabel
Two-Year Safety and Efficacy E ...... in the Latin American Region.
@ast
Two-Year Safety and Efficacy E ...... in the Latin American Region.
@en
P2093
P2860
P1476
Two-Year Safety and Efficacy E ...... in the Latin American Region.
@en
P2093
Bonnie Vlahos
Daniel A Machado
Jesus A Simon
Linda Mele
Renato Guzman
Ronald Pedersen
Sameer Kotak
P2860
P356
10.2174/1874312901610010013
P577
2016-02-29T00:00:00Z